[ Price : $8.95]
Public Citizen says a Senate/House proposed compromise on a drug compounding bill would threaten patient safety by allowing outsou...[ Price : $8.95]
FDA approves a new CSL Behring administration option for Hizentra (immune globulin subcutaneous human), 20% liquid to include dos...[ Price : $8.95]
CDRH Office of Device Evaluation regulations & guidance associate director Ashley Boam says the Center is developing a risk-benefi...[ Price : $8.95]
GlaxoSmithKline says new research challenges FDAs proposed weight of the evidence approach to determining therapeutic equivalence ...[ Price : $8.95]
FDA tells Integra LifeSciences that it has addressed GMP violations cited in a 2011 Warning Letter relating to its Plainsboro, NJ ...[ Price : $8.95]
A Nevada federal court agrees with Medtronic and dismisses as preempted by federal law a suit against the company alleging injurie...[ Price : $8.95]
FDA awards a contract to PointCross Life Sciences for NIMS software development and life cycle management.[ Price : $8.95]
FDA identifies deficiencies in an Amag Feraheme sNDA and delays a decision until 10/21.